GlaxoSmithKline, Prestige Brands Holdings deal

GlaxoSmithKline will divest its non-core consumer healthcare OTC products to Prestige for £426 million ($665.5 million) in cash. The brands had £98 million ($152.6 million) in sales during the first n...